Effect of durvalumab on local control after concurrent chemoradiotherapy for locally advanced non‐small cell lung cancer in comparison with chemoradiotherapy alone

BACKGROUND: Durvalumab after concurrent chemoradiotherapy (CCRT) for locally advanced non‐small cell lung cancer (LA‐NSCLC) has been found to significantly improve overall survival (OS). However, the effect of durvalumab on local control remains unclear. Here, we evaluated the effect of the durvalum...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Thorac Cancer
Главные авторы: Abe, Takanori, Saito, Satoshi, Iino, Misaki, Aoshika, Tomomi, Ryuno, Yasuhiro, Ohta, Tomohiro, Igari, Mitsunobu, Hirai, Ryuta, Kumazaki, Yu, Miura, Yu, Kaira, Kyoichi, Kagamu, Hiroshi, Noda, Shin‐ei, Kato, Shingo
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley & Sons Australia, Ltd 2020
Предметы:
Original Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7812072/
https://ncbi.nlm.nih.gov/pubmed/33289347
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13764
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы